The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016
Access restrictions apply.
ContainerContents
BOX I:4-I:10 Part I: Speeches and Writings File, 1913-1993
Interviews, speeches, background information, drafts of a book, editorials, and miscellaneous writings by Kelsey and others.
Organized according to authorship by Kelsey or others and thereunder by type of material or file.
BOX I:4 By Kelsey
BOX I:4 Interviews, 1962-1963
BOX I:4 Speeches
BOX I:4 List
BOX I:4 Nos. 1-35, 1963-1967
(5 folders)
BOX I:5 Nos. 36-91, 1967-1982
(13 folders)
BOX I:6 Nos. 92-132, 1982-1993
(9 folders)
BOX I:6 Miscellaneous, 1960-1968, 1985
BOX I:6 Writings
BOX I:6 Book, Essentials of Pharmacology
BOX I:6 Outline, undated
BOX I:6 Background information
BOX I:6 Chapter 1, 1913-1990, undated
(2 folders)
BOX I:7 Chapters 2-6, 1930-1992, undated
(7 folders)
BOX I:8 Chapters 7-10, 1945-1993, undated
(7 folders)
BOX I:9 Chapters 11-19b, 1945-1992, undated
(11 folders)
BOX I:10 Chapter 20, 1950-1992, undated
(2 folders)
BOX I:10 Draft, chapters 8-9, undated
(2 folders)
BOX I:10 Editorials, 1950-1962, undated
(3 folders)
BOX I:10 Miscellany, 1962-1968, undated
BOX I:10 By others, articles, 1945, 1957-1991, undated
(3 folders)
BOX I:11-I:35 Part I: Research File, 1917-1998
Correspondence, memoranda, reports, statements, studies, proposals, reviews, guidelines, reprints of articles, newspaper and magazine clippings, press releases, testimonies, minutes, and printed matter.
Arranged alphabetically by subject, name of person or organization, or type of material and thereunder chronologically.
BOX I:11 714X (Drug), United States v. Pixley, 1996
BOX I:11 Abel, John Jacob, biographical material, 1917-1968, undated
BOX I:11 Actinomycin C, 1963
BOX I:11 Adrenocorticoids, undated
BOX I:11 Adverse Drug Effects Advisory Panel, 1975-1976, undated
BOX I:11 Adverse reaction reporting, 1955-1961, 1986-1988, undated
BOX I:11 Aldactone, 1975-1979
BOX I:11 Aldomet, 1961, undated
BOX I:11 Ambodryl hydrochloride compound, 1961, undated
BOX I:11 American Arbitration Association, proposal for ethical review of investigational new drug studies, 1973-1974
BOX I:11 American College of Neuropsychopharmacology, 1977
BOX I:11 Arnold, John D., ethical problems of human experimentation in clinical drug trials, 1975-1988
BOX I:11 Arthur D. Little, Inc., establishment of an integrated agency-wide scientific information system at the U.S. Food and Drug Administration, 1962-1965, undated
(2 folders)
BOX I:11 Avazyme, 1960-1962, undated
BOX I:11 Bamfolin, 1964
BOX I:12 Bendectin, 1979-1981, 1998, undated
(3 folders)
BOX I:12 Benoxaprofen, 1984
BOX I:12 Billings, John Shaw, National Library of Medicine centennial, 1965
BOX I:12 Bismuth sodium triglycollamate (Bistrimate), 1960-1966, undated
BOX I:12 Bureau of Drugs, U.S. Food and Drug Administration, 1971-1973, undated
BOX I:12 Chelation therapy, 1973-1985, undated
BOX I:12 Chloramphenicol, 1961-1968, undated
BOX I:12 Chlordiazepoxide hydrochloride, 1962, undated
BOX I:12 Committees
BOX I:12 Advisory Committee on Investigational Drugs
BOX I:12 1962-1964
BOX I:13 1964-1966, undated
(2 folders)
BOX I:13 Advisory Committee on Protocols for Safety Evaluations, 1966-1967, undated
BOX I:13 Advisory Committee on Psychotomimetic Drugs, 1960-1968, undated
BOX I:13 Citizens Committee, 1960-1962, undated
BOX I:13 Research Involving Human Subjects Committee, 1970-1990
BOX I:13 Congressional hearings
BOX I:13 House of Representatives
BOX I:13 Dingell, John D., investigation into acceptance of subsidized accommodations and related items by U.S. Food and Drug Administration officials, 1989
BOX I:13 Fountain, L. H. (Lawrence), U.S. Food and Drug Administration's oversight of investigational new drugs
BOX I:13 1963-1966
(2 folders)
BOX I:14 1966-1969, undated
BOX I:14 Gore, Albert (1948- ), ethics in biomedical research, 1981
(3 folders)
BOX I:14 Kastenmeier, Robert W., subject studies in vulnerable populations--prisoners, 1973-1975, 1981
(2 folders)
BOX I:14 Senate
BOX I:14 Kefauver, Estes, investigation of drug industry, 1917, 1960-1962, undated
BOX I:15 Kennedy, Edward M., subject studies in vulnerable populations--prisoners, 1962-1978, undated
(4 folders)
BOX I:15 Kennedy, Robert F., LSD (Drug), 1966-1969
BOX I:15 Cumid, 1962, undated
BOX I:15 Cyclert, 1961-1962, undated
BOX I:15 Daroil, 1964-1966
BOX I:15 De Haen, Paul, reports on new pharmaceutical products, 1963-1971
(2 folders)
BOX I:15 Decadron, 1961-1962, undated
BOX I:15 Defoliants and herbicides, 1969-1971, 1996, undated
BOX I:16 DES (Drug)
BOX I:16 Correspondence, 1950-1978
BOX I:16 Memoranda, 1970-1978
BOX I:16 Miscellany, 1950-1978, undated
BOX I:16 Press releases, 1972
BOX I:16 Printed matter, 1948-1985, undated
(2 folders)
BOX I:16 Reports and statements, 1972-1979, undated
BOX I:16 Task force, 1978
BOX I:16 Diapulse device, 1967, 1995
BOX I:16 Dihydrostreptomycin (DHSM), 1953, 1962, undated
BOX I:16 Division of Biologics Standards, U.S. Food and Drug Administration, 1972-1976
BOX I:16 Division of Scientific Investigations, U.S. Food and Drug Administration, 1964, 1985-1987, undated
BOX I:16 DMSO (Drug)
BOX I:16 Bibliography, 1964
BOX I:16 Correspondence, 1965-1967, 1980-1981
(2 folders)
BOX I:17 Leake, Chauncey Depew, consulting editor, Biological Actions of Dimethyl Sulfoxide, 1967
BOX I:17 McGrady, Pat, The Persecuted Drug: The Story of DMSO, 1980
BOX I:17 Memoranda
BOX I:17 Conferences, 1965, 1980-1981
BOX I:17 Miscellaneous, 1965-1966, 1980-1981
BOX I:17 Office, 1964-1988
(2 folders)
BOX I:17 Telephone conversations, 1965-1980
BOX I:17 Miscellany, 1965, undated
BOX I:17 Press releases, 1964-1981
BOX I:18 Printed matter, 1965-1982, undated
(2 folders)
BOX I:18 Reports and statements, 1965-1966, undated
Next Page »

Contents List